[go: up one dir, main page]

WO2000025814A3 - Constituant pour un vaccin - Google Patents

Constituant pour un vaccin Download PDF

Info

Publication number
WO2000025814A3
WO2000025814A3 PCT/GB1999/003559 GB9903559W WO0025814A3 WO 2000025814 A3 WO2000025814 A3 WO 2000025814A3 GB 9903559 W GB9903559 W GB 9903559W WO 0025814 A3 WO0025814 A3 WO 0025814A3
Authority
WO
WIPO (PCT)
Prior art keywords
meningococci
component
vaccine against
against serogroup
serogroup
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB1999/003559
Other languages
English (en)
Other versions
WO2000025814A2 (fr
Inventor
Bambos Michael Charalambous
Ian Michael Feavers
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University College London
National Institute for Biological Standards and Control
Original Assignee
University College London
National Institute for Biological Standards and Control
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University College London, National Institute for Biological Standards and Control filed Critical University College London
Priority to JP2000579253A priority Critical patent/JP2002528517A/ja
Priority to EP99951011A priority patent/EP1124574A2/fr
Publication of WO2000025814A2 publication Critical patent/WO2000025814A2/fr
Publication of WO2000025814A3 publication Critical patent/WO2000025814A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/22—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Neisseriaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Constituant pour un vaccin contre les méningocoques du sérogroupe B, qui comporte un mimotope d'un lipooligosaccharide de surface d'un méningocoque du sérogroupe B.
PCT/GB1999/003559 1998-10-30 1999-10-27 Constituant pour un vaccin Ceased WO2000025814A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP2000579253A JP2002528517A (ja) 1998-10-30 1999-10-27 ワクチン成分
EP99951011A EP1124574A2 (fr) 1998-10-30 1999-10-27 Constituant pour un vaccin

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9823835.5A GB9823835D0 (en) 1998-10-30 1998-10-30 Component for vaccine
GB9823835.5 1998-10-30

Publications (2)

Publication Number Publication Date
WO2000025814A2 WO2000025814A2 (fr) 2000-05-11
WO2000025814A3 true WO2000025814A3 (fr) 2000-07-27

Family

ID=10841614

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1999/003559 Ceased WO2000025814A2 (fr) 1998-10-30 1999-10-27 Constituant pour un vaccin

Country Status (4)

Country Link
EP (1) EP1124574A2 (fr)
JP (1) JP2002528517A (fr)
GB (1) GB9823835D0 (fr)
WO (1) WO2000025814A2 (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0024200D0 (en) * 2000-10-03 2000-11-15 Smithkline Beecham Sa Component vaccine
GB0106315D0 (en) * 2001-03-14 2001-05-02 Ich Productions Ltd Transfection complexes
DK1554305T3 (da) * 2002-10-23 2007-04-23 Ct For Res And Technology Hell Prionprotein-bindende peptidsekvenser
GB0718966D0 (en) * 2007-09-28 2007-11-07 Liverpool School Of Tropical M Bacterial vaccine
AU2019236328B2 (en) * 2018-03-16 2025-10-09 Zoetis Services Llc Peptide vaccines against Interleukin-31
JP7720059B2 (ja) * 2020-02-10 2025-08-07 学校法人順天堂 ２型リアノジン受容体活性抑制剤

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046582A1 (fr) * 1996-06-05 1997-12-11 Peptide Therapeutics Limited Vaccin meningococcique
WO1998008874A1 (fr) * 1996-08-27 1998-03-05 Chiron Corporation Anticorps monoclonaux definissant des epitopes meningococciques b et leurs utilisations dans la preparation de compositions vaccinales

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997046582A1 (fr) * 1996-06-05 1997-12-11 Peptide Therapeutics Limited Vaccin meningococcique
WO1998008874A1 (fr) * 1996-08-27 1998-03-05 Chiron Corporation Anticorps monoclonaux definissant des epitopes meningococciques b et leurs utilisations dans la preparation de compositions vaccinales

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
DATABASE BIOSIS [online] BIOSCIENCES INFORMATION SERVICE, PHILADELPHIA, PA, US; 1996, GAO LIHUI HU XUJING ET AL: "Study on the LOS antigenicity of 2 candidate strains for meningococcal vaccine of serogroup B.", XP002133714, Database accession no. PREV199799335486 *
JONES D M: "Meningococcal vaccines [editorial].", JOURNAL OF MEDICAL MICROBIOLOGY, (1993 FEB) 38 (2) 77-8., XP000891214 *
KIEBER-EMMONS THOMAS: "Peptide mimotopes of carbohydrate antigens.", IMMUNOLOGIC RESEARCH JAN., 1998, vol. 17, no. 1-2, January 1998 (1998-01-01), pages 95 - 108, XP000892784, ISSN: 0257-277X *
ROMERO DIAZ J ET AL: "CURRENT STATUS OF MENINGOCOCCAL GROUP B VACCINE CANDIDATES: CAPSULAR OR NONCAPSULAR?", CLINICAL MICROBIOLOGY REVIEWS,US,WASHINGTON, DC, vol. 7, no. 4, 1 October 1994 (1994-10-01), pages 559 - 575, XP002039373, ISSN: 0893-8512 *
ZHONGHUA WEISHENGWUXUE HE MIANYIXUE ZAZHI 1996, vol. 16, no. 6, 1996, pages 405 - 408, ISSN: 0254-5101 *

Also Published As

Publication number Publication date
EP1124574A2 (fr) 2001-08-22
GB9823835D0 (en) 1998-12-23
WO2000025814A2 (fr) 2000-05-11
JP2002528517A (ja) 2002-09-03

Similar Documents

Publication Publication Date Title
FR11C0001I1 (fr)
CA2463289A1 (fr) Systeme de cimentation pour puits de forage
EP1382135A4 (fr) Procedes de suppression d'interferences pour 802.11
AU3089399A (en) Double mutant enterotoxin for use as an adjuvant
WO2000065402A8 (fr) Verre de contact nacré
WO2001077540A3 (fr) Ensemble embrayage
AUPP396998A0 (en) A method for increasing the permeability of wood
ZA996870B (en) Spring motor for generating constant torque.
MXPA03008856A (es) Metodos para la produccion de lipido a 3-o-desacilado-4¦-monofosforilo (3d-mla).
WO2000025814A3 (fr) Constituant pour un vaccin
AU5405899A (en) A method for the accomplishment secure transaction for electronicbankbook (purse)
WO2001007408A3 (fr) Nouveau procede de preparation de composes benzoperhydroisoindole
AU2994599A (en) Active immunization against angiogenesis-associated antigens
AUPP232798A0 (en) Integrated rankine engine
BR0016668B1 (pt) processo para a preparação de n-fosfonometilglicina, processo para a preparação de um composto fosfono, composto fosfono, e, intermediário.
AU2000234529A1 (en) V.90 over all-digital connections
AU2107400A (en) Neisseria meningitidis antigen
AU4727899A (en) A method for diagnosing selected adenocarcinomas
EP1318017A3 (fr) Poulie pour une machine d'estampage
ZA98738B (en) Mutant enterotoxin effective as a non-toxic adjuvant for hiv.
AU6390001A (en) 6,10-dimethyl-5,9-undecadien-2-ol
AU2001235423A1 (en) Method for producing 2,3,5,6-tetrahalogen-xylylidene compounds
HK1042041A (en) Oral vaccine against diarrhea
AU2002226434A1 (en) A method for diagnosing atrophic gastritis
AU2001289671A1 (en) Bridged glycoconjugates

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref country code: JP

Ref document number: 2000 579253

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1999951011

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1999951011

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 09830702

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 1999951011

Country of ref document: EP